Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TN4785 |
Picrasidine I
|
NF-κB; ROS; MAPK | Immunology/Inflammation; MAPK; NF-κB |
Picrasidine I has antiosteoclastogenic effect by inhibiting inflammation induced activation of MAPKs, NF-κB and ROS generation followed by suppressing the gene expression of c-Fos and NFATc1 in osteoclast precursors. |